We are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company on 27.05.2026 and published in Financial express (English ) and Sanjayvani ( Kannada) on 29.05.2026.
Filing of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.
Audited financial results of the company for the quarter and financial year ended 31.03.2026.
Board of Directors of the Company has met today and transacted following business, 1. Approved audited financial results of the Company for the quarter and financial year ended 31.03.2026. 2.Recommend dividend of Rs1.20 per equity share of Rs.10 each i.e 12% 3.Appointed Cost Auditors and Internal auditors for the financial year 2026.27. 4. Approved grant of 5,00,000 stock options to the employees of the company under "Bal Pharma Ltd-Employee Stock Option Plan-2025" 5.Approved preferential issue of 10,00,000 warrants to the promoters. 6. Take shareholders approval for preferential issue through postal ballot. 7.Approved appointment of Mr.Shreepada M.L (M # A66681) as Company Secretary and compliance officer of the company.
In addition to the agenda items mentioned in our board meeting notice dated 18.05.2025, the following agenda item will also be considered at the meeting scheduled on 27.05.2026. 1. To consider and approve proposal for fund raising through preferential issue of warrants to promoters. All other details and agenda items will remain unchanged. Please take this intimation on record.
Annual Secretarial Compliance Report for the financial year ended 31.03.2026.
1. Audited financial results of the Company for the quarter and financial year ended 31.03.2026. 2. Audited standalone and consolidated accounts of the Company together with auditors report, for the F.Y ended 31.03.2026. 3. To recommend dividend if any, for the F.Y 2025.26. 4. To grant stock options to the employees of the Company under "Bal Pharma Ltd- Employee Stock Option Plan 2025"
Intimation on resignation of Company Secretary & Compliance officer.
Certificate under Regulation 74(5) of SEBI(DP) Regulations, for the quarter ended 31.03.2026.
Closure of Trading Window for the quarter and financial year ended 31.03.2026.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 70.17 | 92.30 | 81.49 | 94.58 | 73.13 | 74.70 | 72.89 | 81.78 | 65.64 | 73.75 | 87.49 | 83.92 |
| YOY Revenue Growth % | 0.94% | 22.98% | 6.44% | 15.38% | 4.22% | -19.07% | -10.56% | -13.53% | -10.25% | -1.27% | 20.04% | 2.61% |
| Other Income | 0.45 | 0.41 | 0.26 | 2.23 | 0.81 | 0.36 | 0.82 | 0.99 | 0.74 | 1.13 | 0.35 | -0.22 |
| Total Income | 70.61 | 92.71 | 81.75 | 96.81 | 73.94 | 75.06 | 73.70 | 82.77 | 66.38 | 74.88 | 87.84 | 83.70 |
| Total Expenses + | 69.08 | 90.48 | 80.08 | 90.14 | 71.84 | 73.52 | 72.50 | 79.96 | 66.05 | 74.10 | 85.89 | 80.39 |
| Cost of Materials Consumed | 41.57 | 50.19 | 37.92 | 51.89 | 36.31 | 36.13 | 37.55 | 39.92 | 36.03 | 40.29 | 43.51 | 41.14 |
| Employee Benefit Expense | 13.20 | 14.18 | 14.17 | 14.56 | 13.84 | 14.88 | 14.81 | 15.35 | 14.67 | 16.15 | 17.19 | 17.92 |
| Other Expenses | 11.34 | 17.14 | 13.84 | 15.94 | 13.27 | 14.12 | 13.66 | 14.66 | 11.33 | 11.98 | 14.49 | 16.99 |
| Operating Profit | 1.08 | 1.82 | 1.42 | 4.44 | 1.29 | 1.18 | 0.38 | 1.82 | -0.42 | -0.35 | 1.60 | 3.53 |
| OPM % | 1.5% | 2% | 1.7% | 4.7% | 1.8% | 1.6% | 0.5% | 2.2% | -0.6% | -0.5% | 1.8% | 4.2% |
| Profit Before Tax + | 1.53 | 2.23 | 1.67 | 6.67 | 2.11 | 1.53 | 1.20 | 2.81 | 0.32 | 0.78 | 1.95 | 3.31 |
| Tax Expense | 0.34 | 0.63 | 0.42 | 0.45 | 0.36 | 0.32 | 0.05 | -2.79 | 0.00 | 0.00 | 0.00 | -0.39 |
| Tax % | 21.9% | 28.2% | 24.9% | 6.8% | 17% | 20.8% | 4% | -99.3% | 0% | 0% | 0% | -11.7% |
| Profit After Tax | 1.20 | 1.60 | 1.26 | 6.22 | 1.75 | 1.21 | 1.16 | 5.61 | 0.32 | 0.78 | 1.95 | 3.70 |
| EPS (Basic) | 0.76 | 1.02 | 0.80 | 4.16 | 1.11 | 0.76 | 0.73 | 3.51 | 0.20 | 0.49 | 1.22 | 2.60 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 310.80 | 302.50 | 338.54 | 303.10 | 280.37 | 249.31 | 170.67 |
| YOY Revenue Growth % | 2.74% | -10.65% | 11.69% | 8.11% | 12.46% | 46.07% | - |
| Other Income | 2.00 | 2.15 | 3.35 | 2.15 | 6.49 | 2.70 | 3.62 |
| Total Income | 312.80 | 304.65 | 341.89 | 305.25 | 286.86 | 252.01 | 174.29 |
| Total Expenses + | 306.43 | 298.91 | 329.79 | 296.70 | 274.80 | 242.20 | 159.14 |
| Cost of Materials Consumed | 160.97 | 149.89 | 181.57 | 176.45 | 162.95 | 135.47 | 79.44 |
| Employee Benefit Expense | 65.92 | 61.83 | 56.11 | 51.91 | 44.46 | 39.62 | 48.77 |
| Other Expenses | 54.79 | 52.82 | 58.25 | 55.22 | 46.21 | 32.79 | 30.93 |
| Operating Profit | 4.36 | 3.58 | 8.75 | 6.39 | 5.57 | 7.10 | 11.53 |
| OPM % | 1.4% | 1.2% | 2.6% | 2.1% | 2% | 2.8% | 6.8% |
| Profit Before Exceptional | 6.37 | 5.73 | 12.11 | 8.55 | 12.06 | 9.80 | -9.57 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 6.37 | 5.73 | 12.11 | 8.55 | 12.06 | 9.80 | -9.57 |
| Tax Expense | -0.39 | -2.07 | 1.83 | 2.42 | 3.48 | 0.70 | -0.04 |
| Tax % | -6.1% | -36.1% | 15.1% | 28.3% | 28.9% | 7.1% | - |
| Profit After Tax | 6.75 | 7.80 | 10.27 | 6.13 | 8.57 | 9.10 | -9.53 |
| EPS (Basic) | 4.27 | 4.89 | 6.72 | 3.90 | 5.79 | 6.41 | -13.44 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Non-Current Assets + | 115.42 | 102.91 | 80.16 | 77.75 | 69.35 | 68.34 | 0.00 |
| Property, Plant & Equipment | 76.73 | 70.95 | 53.18 | 52.62 | 44.92 | 45.42 | 0.00 |
| Capital Work in Progress | 7.42 | 2.79 | 0.47 | 0.00 | 1.16 | 0.00 | 0.00 |
| Non-Current Investments | 2.16 | 2.16 | 9.58 | 0.00 | 0.00 | 8.40 | 0.00 |
| Goodwill | 3.83 | 3.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 13.42 | 12.00 | 11.38 | 10.45 | 7.98 | 7.23 | 0.00 |
| Current Assets + | 275.64 | 247.65 | 281.14 | 269.95 | 220.27 | 193.20 | 0.00 |
| Inventories | 116.13 | 102.78 | 87.49 | 97.69 | 73.97 | 60.12 | 0.00 |
| Trade Receivables | 96.36 | 94.85 | 103.10 | 94.84 | 77.91 | 69.44 | 0.00 |
| Cash and Cash Equivalents | 2.19 | 1.64 | 4.04 | 1.23 | 0.81 | 0.89 | 0.00 |
| Current Investments | 2.08 | 2.47 | 6.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | |||||||
| Total Equity | 104.10 | 98.82 | 105.58 | 96.03 | 87.32 | 79.32 | 0.00 |
| Equity Share Capital | 15.92 | 15.92 | 15.80 | 15.69 | 14.82 | 14.82 | 0.00 |
| Other Equity | 88.18 | 82.90 | 89.78 | 80.34 | 72.50 | 64.50 | 0.00 |
| Non-Current Liabilities | 43.65 | 38.28 | 46.56 | 39.52 | 40.18 | 35.35 | 0.00 |
| Current Liabilities | 243.30 | 213.46 | 209.16 | 212.15 | 93.58 | 146.87 | 0.00 |
| Total Liabilities | 286.96 | 251.74 | 255.72 | 251.67 | 202.29 | 182.22 | 0.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 8.82 | 20.31 | 33.35 | -8.50 | 18.42 | 11.47 | 0.00 |
| Cash from Investing Activities | -26.82 | -14.90 | 2.57 | -17.95 | 30.76 | 0.00 | 0.00 |
| Cash from Financing Activities | -11.76 | -7.83 | 24.21 | 0.00 | 0.00 | -18.63 | 0.00 |
| Net Increase/Decrease in Cash | -28.45 | -2.42 | 60.13 | -26.45 | 49.18 | -7.16 | 0.00 |